Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1970 Mar;38(3):546–553. doi: 10.1111/j.1476-5381.1970.tb10596.x

Comparison of the effects of propranolol and MJ 1999 on cardiac β-adrenoceptors in man

J M Kofi Ekue, D C Lowe, R G Shanks
PMCID: PMC1702574  PMID: 4392540

Abstract

1. Propranolol, a β-adrenoceptor blocking drug with local anaesthetic and a direct myocardial depressant action, and MJ 1999, a β-adrenoceptor blocking drug which has no local anaesthetic or intrinsic sympathomimetic action, were compared for β-adrenoceptor blocking activity in man.

2. Propranolol was 2·67 times more active than MJ 1999 in reducing by 50% the tachycardia produced by the intravenous infusion of isoprenaline in healthy volunteers.

3. Propranolol and MJ 1999 intravenously both reduced resting heart rate in the standing position and an exercise tachycardia, but there was no qualitative or quantitative difference between them.

4. On oral administration, both propranolol and MJ 1999 reduced resting heart rate and an exercise induced tachycardia; propranolol was only slightly more active than MJ 1999.

5. In patients with thyrotoxicosis propranolol was about twice as active as MJ 1999 in reducing the heart rate.

Full text

PDF
546

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ablad B., Johnsson G., Norrby A., Sölvell L. Potency and time-effect relationship in man of propranolol and H 56-28--comparative studies after oral administration. Acta Pharmacol Toxicol (Copenh) 1967;25:85–94. doi: 10.1111/j.1600-0773.1967.tb02999.x. [DOI] [PubMed] [Google Scholar]
  2. BLACK J. W., STEPHENSON J. S. Pharmacology of a new adrenergic beta-receptor-blocking compound (Nethalide). Lancet. 1962 Aug 18;2(7251):311–314. doi: 10.1016/s0140-6736(62)90103-4. [DOI] [PubMed] [Google Scholar]
  3. Brick I., Hutchison K. J., McDevitt D. G., Roddie I. C., Shanks R. G. Comparison of the effects of I.C.I. 50172 and propranolol on the cardiovascular responses to adrenaline, isoprenaline and exercise. Br J Pharmacol. 1968 Sep;34(1):127–140. doi: 10.1111/j.1476-5381.1968.tb07956.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fitzgerald J. D. Perspectives in adrenergic beta-receptor blockade. Clin Pharmacol Ther. 1969 May-Jun;10(3):292–306. doi: 10.1002/cpt1969103292. [DOI] [PubMed] [Google Scholar]
  5. Frankl W. S., Soloff L. A. Sotalol: a new, safe beta adrenergic receptor blocking agent. Am J Cardiol. 1968 Aug;22(2):266–272. doi: 10.1016/0002-9149(68)90233-6. [DOI] [PubMed] [Google Scholar]
  6. Harris W. S., Schoenfeld C. D., Brooks R. H., Weissler A. M. Effect of beta adrenergic blockade on the hemodynamic responses to epinephrine in man. Am J Cardiol. 1966 Apr;17(4):484–492. doi: 10.1016/0002-9149(66)90238-4. [DOI] [PubMed] [Google Scholar]
  7. Hill R. C., Turner P. Preliminary investigations of a new beta-adrenoceptive receptor blocking drug, LB46, in man. Br J Pharmacol. 1969 Jun;36(2):368–372. doi: 10.1111/j.1476-5381.1969.tb09511.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Levy J. V. Myocardial and local anesthetic actions of beta-adrenergic receptor blocking drugs: relationship to physicochemical properties. Eur J Pharmacol. 1968 Feb;2(4):250–257. doi: 10.1016/0014-2999(68)90074-5. [DOI] [PubMed] [Google Scholar]
  9. Levy J. V., Richards V. Inotropic and chronotropic effects of a series of beta-adrenergic blocking drugs: some structure-activity relationships. Proc Soc Exp Biol Med. 1966 Jun;122(2):373–379. doi: 10.3181/00379727-122-31138. [DOI] [PubMed] [Google Scholar]
  10. Lish P. M., Shelanski M. V., LaBudde J. A., Williams W. R. Inhibition of cardiac chronotropic action of isoproterenol by Sotalol (MJ 1999) in rat, dog and man. Curr Ther Res Clin Exp. 1967 Jun;9(6):311–324. [PubMed] [Google Scholar]
  11. Lish P. M., Weikel J. H., Dungan K. W. Pharmacological and toxicological properties of two new beta-adrenergic receptor antagonists. J Pharmacol Exp Ther. 1965 Aug;149(2):161–173. [PubMed] [Google Scholar]
  12. MORALES AGUILERA A., VAUGHANWILLIAMS E. M. THE EFFECTS ON CARDIAC MUSCLE OF BETA-RECEPTOR ANTAGONISTS IN RELATION TO THEIR ACTIVITY AS LOCAL ANAESTHETICS. Br J Pharmacol Chemother. 1965 Apr;24:332–338. doi: 10.1111/j.1476-5381.1965.tb01719.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. McDevitt D. G., Shanks R. G., Hadden D. R., Montgomery D. A., Weaver J. A. The role of the thyroid in the control of heart-rate. Lancet. 1968 May 11;1(7550):998–1000. doi: 10.1016/s0140-6736(68)91109-4. [DOI] [PubMed] [Google Scholar]
  14. Turner P., Hill R. C. A comparison of three beta-adrenergic receptor-blocking drugs in thyrotoxic tachycardia. J Clin Pharmacol J New Drugs. 1968 Jul-Aug;8(4):268–271. doi: 10.1002/j.1552-4604.1968.tb00104.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES